Differential response of psoriatic onycho-pachydermo-periostitis to 2 anti-tumor necrosis factor-alpha agents.
Morton Allan
MA
Kapusta
Charles
C
Dumont
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D054039:Onycholysis / Q000188:drug therapy / Q000209:etiology; D010522:Periostitis / Q000150:complications / Q000188:drug therapy*; D013577:Syndrome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab